CNC
Centene Corporation
NYSE Healthcare United States
68,63 $US
-0.77% today
+64.27% YTD · +92.73% 1Y
8
Insider transactions
SEC Form 4 · AMF · BaFin — rolling 90 days
33
Hedge funds tracked
Latest available SEC 13F filings
69
/ 100
STRONG

Analysis Centene Corporation (CNC) — Kairos Score 69/100

Composite score aggregating 8 smart money dimensions: insiders (SEC/AMF/BaFin), hedge funds, politicians & gurus, price momentum, valuation, analyst consensus, financial health, earnings momentum. The higher the score, the more favorable the institutional signals consensus.

💡 Detailed breakdown (the 8 sub-scores) available in the Premium dashboard.

About Centene Corporation

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Key info

👔
CEO
Ms. Sarah M. London
📍
HQ
Centene Plaza, 7700 Forsyth Boulevard, Saint Louis, MO, 63105, United States
👥
Employees
61 100
💰
Market cap
33 902 876 672,00 $US
💸
Dividend yield
0.00%

🕴️ Insider activity (90 days)

8 transactions — 0 buys and 1 sales reported by Centene Corporation executives.

CM
Carson Michael A
Group President, Medicare&Spec · 2026-10-15
Other
TL
Tyler Lauren M
2026-09-30
Other
TK
TANJI KENNETH
2026-09-30
Other

🏦 Hedge Funds

33 institutional funds report a position on CNC in their latest SEC quarterly filing.

BlackRock, Inc.
VANGUARD GROUP INC
VANGUARD CAPITAL MANAGEMENT LLC
AQR CAPITAL MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC

📰 Recent news

15 recent articles on CNC.

🧠 What makes Kairos Insider

Beyond raw data, we aggregate and score every smart money signal to give you a unique view.

🧠

Kairos Score 0-100

8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.

🎯

Insider Clusters

Detection of clustered purchases or sales by several executives in the same stock.

🏦

13F Hedge Funds

Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.

📈

ETF Rotations

NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.

🔥

Google Trends

Spot marked changes in search interest around the stocks being followed.

📧

Email alerts

Create your watchlist and receive a brief of events affecting your tickers.

Companies in the same sector as Centene Corporation

Official sources · Public data · SEC EDGAR — Form 4 & 13F · AMF — Executive filings · BaFin — Directors' Dealings · Yahoo Finance · Alpha Vantage

🔓 Unlock the full analysis

This public page only shows a preview. The full analysis of CNC on the Kairos Insider dashboard includes:

✅ Full Kairos Score (8-axis radar + synthesis)
✅ History of all 8 insider transactions over 90 days
✅ All 33 detected institutional funds
✅ Thematic ETFs (ARK, BUZZ, NANC, GOP, JEPI…)
✅ Hot Stocks Google Trends
✅ Available history: AUM + rotations
✅ Fundamentals (P/E, PEG, EV/EBITDA, ROE…)
✅ Financial health (Altman Z, Piotroski F)
✅ Sector peers + recent earnings
See full analysis →
Analyze other tickers for free →

Free signup · Pro €19/month or €190/year